Rheumatoid arthritis probably induced by pegylated interferon in a patient with chronic hepatitis C.
We report a 47-year-old woman who developed features of rheumatoid arthritis 20 weeks after initiation of treatment with pegylated interferon and ribavirin for chronic hepatitis C. She continued to have symptoms six months after discontinuation of the drugs which she received for 24 weeks with rival clearance.
Sood
Ajit
A
Department of Medicine, Dayanand Medical College and Hospital, Ludhiana, Punjab. ajitsood10@sify.com
Midha
Vandana
V
Sood
Neena
N
D000998:Antiviral Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000139:chemically induced*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000009:adverse effects*; D011994:Recombinant Proteins
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a